HURA
Price
$2.48
Change
-$0.13 (-4.98%)
Updated
Jul 3 closing price
Capitalization
115.44M
OCS
Price
$18.66
Change
-$0.34 (-1.79%)
Updated
Jul 7, 11:35 AM (EDT)
Capitalization
969.64M
Interact to see
Advertisement

HURA vs OCS

Header iconHURA vs OCS Comparison
Open Charts HURA vs OCSBanner chart's image
TuHURA Biosciences
Price$2.48
Change-$0.13 (-4.98%)
Volume$603.78K
Capitalization115.44M
Oculis Holding AG
Price$18.66
Change-$0.34 (-1.79%)
Volume$350
Capitalization969.64M
HURA vs OCS Comparison Chart in %
Loading...
HURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HURA vs. OCS commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HURA is a Buy and OCS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (HURA: $2.48 vs. OCS: $19.00)
Brand notoriety: HURA and OCS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HURA: 244% vs. OCS: 30%
Market capitalization -- HURA: $115.44M vs. OCS: $969.64M
HURA [@Biotechnology] is valued at $115.44M. OCS’s [@Biotechnology] market capitalization is $969.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HURA’s FA Score shows that 0 FA rating(s) are green whileOCS’s FA Score has 0 green FA rating(s).

  • HURA’s FA Score: 0 green, 5 red.
  • OCS’s FA Score: 0 green, 5 red.
According to our system of comparison, OCS is a better buy in the long-term than HURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HURA’s TA Score shows that 4 TA indicator(s) are bullish while OCS’s TA Score has 3 bullish TA indicator(s).

  • HURA’s TA Score: 4 bullish, 4 bearish.
  • OCS’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both HURA and OCS are a good buy in the short-term.

Price Growth

HURA (@Biotechnology) experienced а +11.21% price change this week, while OCS (@Biotechnology) price change was -2.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.61%. For the same industry, the average monthly price growth was +13.95%, and the average quarterly price growth was -0.52%.

Industries' Descriptions

@Biotechnology (+5.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCS($970M) has a higher market cap than HURA($115M). OCS YTD gains are higher at: 11.765 vs. HURA (-39.364). HURA has higher annual earnings (EBITDA): -19.52M vs. OCS (-101.78M). OCS has more cash in the bank: 182M vs. HURA (6.22M). HURA has less debt than OCS: HURA (165K) vs OCS (1.1M). HURA (0) and OCS (0) have equivalent revenues.
HURAOCSHURA / OCS
Capitalization115M970M12%
EBITDA-19.52M-101.78M19%
Gain YTD-39.36411.765-335%
P/E RatioN/A63.06-
Revenue00-
Total Cash6.22M182M3%
Total Debt165K1.1M15%
FUNDAMENTALS RATINGS
HURA: Fundamental Ratings
HURA
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HURAOCS
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 5 days ago
50%
Momentum
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
34%
MACD
ODDS (%)
Bullish Trend 5 days ago
74%
Bearish Trend 5 days ago
42%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
48%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
48%
Advances
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 21 days ago
72%
Declines
ODDS (%)
Bearish Trend 25 days ago
90%
Bearish Trend 18 days ago
63%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
HURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISGNX15.730.22
+1.42%
Columbia Integrated Small Cap Gr Instl
DCFGX36.700.48
+1.33%
Dunham Focused Large Cap Growth C
JDNAX76.530.68
+0.90%
Janus Henderson Growth And Income A
RUNTX25.420.20
+0.79%
Russell Inv US Small Cap Equity M
EIVFX14.240.07
+0.49%
Allspring Special Large Cap Value R6

HURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HURA has been closely correlated with BIORQ. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if HURA jumps, then BIORQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HURA
1D Price
Change %
HURA100%
+0.40%
BIORQ - HURA
73%
Closely correlated
-6.25%
GNPX - HURA
60%
Loosely correlated
-3.59%
SNSE - HURA
48%
Loosely correlated
-2.54%
BIVI - HURA
47%
Loosely correlated
-1.07%
INAB - HURA
36%
Loosely correlated
+0.93%
More

OCS and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with HURA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
-0.81%
HURA - OCS
35%
Loosely correlated
+0.40%
SNSE - OCS
34%
Loosely correlated
-2.54%
CUE - OCS
33%
Loosely correlated
+0.46%
BIORQ - OCS
31%
Poorly correlated
-6.25%
CGEN - OCS
29%
Poorly correlated
+1.15%
More